Search





Search





Sidewinder Therapeutics Announces $137 Million Series B Financing To Advance Precision Bispecific ADCs Into Clinical Development For Cancer

ReutersApr 8, 2026 12:12 PM

April 8 (Reuters) -

SIDEWINDER THERAPEUTICS ANNOUNCES $137 MILLION SERIES B FINANCING TO ADVANCE PRECISION BISPECIFIC ADCS INTO CLINICAL DEVELOPMENT FOR CANCER
SIDEWINDER THERAPEUTICS: FINANCING CO-LED BY FRAZIER LIFE SCIENCES AND NOVARTIS VENTURE FUND
SIDEWINDER THERAPEUTICS: FINANCING WITH PARTICIPATION FROM ORBIMED, LIFE SCIENCES AT GOLDMAN SACHS ALTERNATIVES, DCVC BIO, SAMSARA BIOCAPITAL, OTHERS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Anthropic Claude Mythos Preview Sparks Wall Street Panic: Bessent, Powell Summon CEOs; Cloudflare Tumbles 8%

TradingKey - According to the latest Bloomberg report, U.S. Treasury Secretary Bessent and Federal Reserve Chair Jerome Powell urgently convened a meeting with the CEOs of major Wall Street banks this Tuesday to discuss potential cybersecurity threats posed by Anthropic's latest AI model, Mythos. Th

Tesla Denies Developing Small Electric SUV, Is It Giving up on the Mass Market?

TradingKey - April 10, 2026: Tesla China officially refuted market rumors claiming the company is "secretly developing a smaller, more affordable electric SUV (4.28 meters long, priced below the Model 3, with production planned at the Shanghai factory)." These reports have been explicitly denied.

SpaceX Eyes IPO Amid Exposed $5B Loss: Will xAI 'Burn Rate' Drag Down $2T Valuation?

TradingKey - The Information reports that SpaceX's 2025 revenue exceeded $18.5 billion, while net losses approached $5 billion. Analysis suggests these figures reflect the drag on SpaceX following its merger with xAI. Influenced by xAI, will SpaceX's target IPO valuation be significantly discounted?

Nvidia Rises for Seven Straight Days, AI Chip Leader’s Stock May Break All-Time High

TradingKey - On Thursday (April 10), Nvidia shares closed approximately 1% higher at $183.94, marking its seventh consecutive session of gains and its longest winning streak since November 2023. While the magnitude of this rally is not particularly dramatic, its significance lies in the market’s renewed willingness to buy into Nvidia's AI growth story following months of repeated volatility.

From 14.2 Billion to 21 Billion, Why Meta Continues to Bet on CoreWeave?

TradingKey - On April 9, AI cloud computing provider CoreWeave (CRWV) announced a long-term partnership agreement valued at $21 billion with Meta (META). The company will provide Meta with dedicated AI cloud computing capacity, with the service term extending through December 2032.

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

link

SpaceX IPO Guide: Can You Buy SpaceX IPO Shares on Robinhood? How Can Investors in Asia and Europe Buy SpaceX IPO Shares?

Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market

Tradingkey

Tradingkey

KeyAI

